Contact Information
1770 Massachusetts Avenue# 274
Cambridge, MA 02140-2808
Phone: +1 617 497 7774
Contact: David Warshawsky, Ph.D.
Email: davidw@xennexinc.com
Website: http://www.xennexinc.com
Xennex Inc. Company Profile
Founded in 2003, Xennex, Inc. (http://www.xennexinc.com) is a dynamic privately held company that is dedicated to providing Biotechnology, Pharmaceutical and other life sciences companies, as well as organizations dealing with biotechnology intellectual property, the highest level of services and tools to enhance their gene-based research. Xennex’ products help such organizations to optimize their efforts to develop innovative medical products and services. Xennex’ customers include many of the world’s leading Biotech and Pharmaceutical companies and organizations dealing with intellectual property, located in North America, Europe and Japan. Xennex’ products are used in hundreds of commercial and academic organizations by tens of thousands of users around the globe.News from Xennex Inc.:
GeneCards® Version 3.07 Released
CAMBRIDGE, Mass., Nov. 14, 2011 — Xennex Inc. (Xennex) announced today the release of GeneCards®, Version 3.07, available at www.genecards.org.
The new GeneCards release includes 68,445 Entries, 32,088 of them with symbols ap…
GeneCards(R) Version 3.0 Released
HANOVER, Mass., March 2, 2010 – Xennex, Inc. (Xennex) announced today the release of GeneCards(R), Version 3.0, available at http://www.genecards.org.
GeneCards Version 3.0 was introduced as a trial release in May 2009 and is no…
GeneCards(R) Version 3.0 Beta Released
CAMBRIDGE, Mass., May 13, 2009 — Xennex, Inc. (Xennex) announced today a major leap for GeneCards(R) with the release of Version 3.0 beta, available at .
The new GeneCards Version 3.0 features a significantly upgraded infrastruct…
Xennex Inc. Providing Satoris Inc. with Latest GeneCards(R) Tools for Characterization of Protein Biomarkers Associated With Neurological Conditions
CAMBRIDGE, Mass., April 20, 2009 — Xennex Inc. (Xennex) announced today that it is collaborating with Satoris Inc. (Satoris) and has provided Satoris with access to GeneCards(R) and associated proprietary tools, including Gene…
Japan Patent Office Licenses GeneCards(R) from Xennex, Inc.
Xennex, Inc. Partners with Bioscene in Japan – Expands Presence in Japan
CAMBRIDGE, Mass., May 5, 2008 — Xennex, Inc. (Xennex) announced today that the Japan Patent Office (JPO) has licensed GeneCards(R). Xennex also annou…
European Patent Office Licenses GeneCards(R) From Xennex, Inc.
GeneCards(R) to be Used to Determine Prior Art in Patent Research and Approval Process throughout Europe
CAMBRIDGE, Mass., March 29, 2005 — Xennex, Inc. announced today that the European Patent Office (EPO) has licensed its GeneC…